v3.26.3
Label Element Value
GMO U.S. Equity Fund | GMO U.S. Equity Fund  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk/Return [Heading] oef_RiskReturnHeading ​  GMO U.S. EQUITY FUND   ​
Objective [Heading] oef_ObjectiveHeading Investment objective
Objective, Primary [Text Block] oef_ObjectivePrimaryTextBlock
High total return.
Expense Heading [Optional Text] oef_ExpenseHeading Fees and expenses
Expense Narrative [Text Block] oef_ExpenseNarrativeTextBlock
The table below describes the fees and expenses that you may bear for each class of shares if you buy, hold, and sell shares of the Fund. You may pay other fees, such as brokerage commissions and other fees to financial intermediaries, which are not reflected in the table and example below.
Operating Expenses Caption [Optional Text] oef_OperatingExpensesCaption Annual Fund operating expenses (expenses that you bear each year as a percentage of the value of your investment)
Fee Waiver or Reimbursement over Assets, Date of Termination oef_FeeWaiverOrReimbursementOverAssetsDateOfTermination Sep. 30, 2027
Other Expenses, New Fund, Based on Estimates [Text] oef_OtherExpensesNewFundBasedOnEstimates Because ETF Class shares of the Fund are new, “Other expenses” are estimated amounts for the current fiscal year based on the expenses of Class R6 shares of the Fund.
Expense Example [Heading] oef_ExpenseExampleHeading Example
Expense Example Narrative [Text Block] oef_ExpenseExampleNarrativeTextBlock
This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated, regardless of whether or not you sell your shares at the end of such periods. The example also assumes that your investment has a 5% return each year and that the Fund’s operating expenses with respect to ETF Class shares remain the same as those shown in the table. The one year amounts shown reflect the expense reimbursement and waiver noted in the expense table. Although your actual costs may be higher or lower, based on these assumptions your costs would be:
Portfolio Turnover [Heading] oef_PortfolioTurnoverHeading Portfolio turnover
Portfolio Turnover [Text Block] oef_PortfolioTurnoverTextBlock
The Fund pays transaction costs, such as commissions, when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, for holders of Fund shares subject to U.S. taxes, higher income taxes. These transaction costs, which are not reflected in Annual Fund operating expenses or in the Example, affect the Fund’s performance. During its fiscal year ended February 28, 2026, the Fund’s portfolio turnover rate (excluding short-term investments) was 101% of the average value of its portfolio securities. That portfolio turnover rate includes investments in U.S. Treasury Fund, which the Fund uses as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during its fiscal year ended February 28, 2026, excluding transactions in U.S. Treasury Fund and other short-term investments, was 95% of the average value of its portfolio securities.
Portfolio Turnover, Rate oef_PortfolioTurnoverRate 101.00%
Strategy [Heading] oef_StrategyHeading Principal investment strategies
Strategy Narrative [Text Block] oef_StrategyNarrativeTextBlock
GMO seeks to achieve the Fund’s investment objective by investing the Fund’s assets primarily in securities traded in U.S. equity markets. GMO selects the securities the Fund buys and sells based on its evaluation of companies’ published financial information, securities’ prices, equity and other markets, the overall global economy, and governmental policies.
In selecting securities for the Fund, GMO uses a combination of proprietary quantitative investment methods to identify U.S. equities GMO believes have positive return potential relative to other U.S. equities. Some of these methods evaluate individual companies or groups of companies based on the ratio of their security price to historical financial information and forecasted financial information, such as return on invested capital, profitability, cash flow and earnings, and a comparison of these ratios to current and historical averages. Other methods
focus on patterns of information, such as price movement or volatility of an asset class, security, or market, and macroeconomic factors. In constructing the Fund’s portfolio, GMO also considers position size, sector and industry exposure, market capitalization, liquidity, and transaction costs. At times, the Fund may have substantial exposure to a single asset class, industry, sector and companies with similar market capitalizations. The Fund may invest in securities of companies of any market capitalization. GMO also may consider ESG (environmental, social and governance) criteria. For example, GMO generally avoids investing the Fund’s assets in companies engaged in the manufacture, supply, or distribution of cluster munitions, as well as companies primarily involved in the mining and production of thermal coal. The factors GMO considers and investment methods GMO uses can change over time.
As an alternative to investing directly in equities, the Fund may invest in exchange-traded and over-the-counter (OTC) derivatives and exchange-traded funds (ETFs). The Fund also may invest in derivatives and ETFs in an attempt to obtain or adjust elements of its long or short investment exposure. Derivatives used may include futures, options, and swap contracts. In addition, the Fund may lend its portfolio securities.
Under normal circumstances, the Fund invests directly and indirectly (e.g., through underlying funds or derivatives) at least 80% of its assets in equities tied economically to the United States (see “Name Policies”).
The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.
The Fund’s ETF Class operates as an actively managed exchange-traded fund (“ETF”).
Rule 35d-1 Eighty Percent Investment Policy [Text Block] fnd_NmRule35d1EightyPctInvstmntPlcyTextBlock Under normal circumstances, the Fund invests directly and indirectly (e.g., through underlying funds or derivatives) at least 80% of its assets in equities tied economically to the United States (see “Name Policies”).
Bar Chart and Performance Table [Heading] oef_BarChartAndPerformanceTableHeading Performance
Performance Narrative [Text Block] oef_PerformanceNarrativeTextBlock
The bar chart and table below provide some indication of the risks of investing in the Fund by showing changes in the Fund’s annual total returns from year to year for the periods indicated and by comparing the Fund’s average annual total returns for different calendar periods with those of a broad-based securities market index. The Fund’s ETF Class shares are a new class and, as of the date of this Prospectus, had not commenced operations. Returns shown are those of Class III shares of the Fund, a mutual fund class of shares of the Fund not offered in this Prospectus, and have not been adjusted to reflect the fees and expenses attributable to ETF Class shares. Class III shares would have substantially similar annual returns to ETF Class shares because the shares are invested in the same portfolio of securities, and the annual returns at NAV (assuming ETF Class shares are bought and sold without any premium or discount) would differ only to the extent that Class III shares do not have the same expenses as ETF Class shares. Share classes that bear higher expenses than the share classes shown below would have lower returns. After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on your tax situation and may differ from those shown. After-tax returns shown are not relevant if you are tax-exempt or if you hold your Fund shares through tax-advantaged arrangements (such as a 401(k) plan or individual retirement account). After-tax returns are shown for Class III shares only; after-tax returns for other classes will vary. Updated performance information for the Fund is available at https://www.gmo.com/americas/investment-capabilities/etfs/. Past performance (before and after taxes) is not an indication of future performance.
Performance Information Illustrates Variability of Returns [Text] oef_PerformanceInformationIllustratesVariabilityOfReturns The bar chart and table below provide some indication of the risks of investing in the Fund by showing changes in the Fund’s annual total returns from year to year for the periods indicated and by comparing the Fund’s average annual total returns for different calendar periods with those of a broad-based securities market index.
Performance One Year or Less [Text] oef_PerformanceOneYearOrLess The Fund’s ETF Class shares are a new class and, as of the date of this Prospectus, had not commenced operations.
Performance Availability Website Address [Text] oef_PerformanceAvailabilityWebSiteAddress https://www.gmo.com/americas/investment-capabilities/etfs/
Performance Past Does Not Indicate Future [Text] oef_PerformancePastDoesNotIndicateFuture Past performance (before and after taxes) is not an indication of future performance.
Bar Chart [Heading] oef_BarChartHeading Annual Total Returns/Class III Shares1 Years Ending December 31
Bar Chart Footnotes [Text Block] oef_BarChartFootnotesTextBlock

The Fund is the successor to GMO U.S. Core Fund, a former series of GMO Trust that had an investment objective and investment policies and restrictions substantially identical to those of the Fund. Performance of the Fund through September 16, 2005 is that of GMO U.S. Core Fund and reflects GMO U.S. Core Fund’s annual operating expenses (0.02% higher than those of the Fund).
Bar Chart Closing [Text Block] oef_BarChartClosingTextBlock
Highest Quarter: 19.81% 2Q 2020
Lowest Quarter: -21.15% 1Q 2020
Year-to-Date: 14.57% As of 6/30/2026
Year to Date Return, Label [Optional Text] oef_YearToDateReturnLabel Year-to-Date:
Bar Chart, Year to Date Return, Date oef_BarChartYearToDateReturnDate Jun. 30, 2026
Bar Chart, Year to Date Return oef_BarChartYearToDateReturn 14.57%
Highest Quarterly Return, Label [Optional Text] oef_HighestQuarterlyReturnLabel Highest Quarter:
Highest Quarterly Return, Date oef_BarChartHighestQuarterlyReturnDate Jun. 30, 2020
Highest Quarterly Return oef_BarChartHighestQuarterlyReturn 19.81%
Lowest Quarterly Return, Label [Optional Text] oef_LowestQuarterlyReturnLabel Lowest Quarter:
Lowest Quarterly Return, Date oef_BarChartLowestQuarterlyReturnDate Mar. 31, 2020
Lowest Quarterly Return oef_BarChartLowestQuarterlyReturn (21.15%)
Performance Table Heading oef_PerformanceTableHeading Average Annual Total Returns1 Periods Ending December 31, 2025
Index No Deduction for Fees, Expenses, or Taxes [Text] oef_IndexNoDeductionForFeesExpensesTaxes (returns reflect no deduction for fees, expenses, or taxes)
Performance Table Uses Highest Federal Rate oef_PerformanceTableUsesHighestFederalRate After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes.
Performance Table Not Relevant to Tax Deferred oef_PerformanceTableNotRelevantToTaxDeferred Actual after-tax returns depend on your tax situation and may differ from those shown. After-tax returns shown are not relevant if you are tax-exempt or if you hold your Fund shares through tax-advantaged arrangements (such as a 401(k) plan or individual retirement account).
Performance Table One Class of after Tax Shown [Text] oef_PerformanceTableOneClassOfAfterTaxShown After-tax returns are shown for Class III shares only; after-tax returns for other classes will vary.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Risk Lose Money [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock Many factors can affect this value, and you may lose money by investing in the Fund.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Risk Not Insured [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock An investment in the Fund is not a bank deposit and is not insured or guaranteed by the FDIC or any government agency.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Market Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Market Risk – Equities − The market price of an equity in the Fund’s portfolio may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. If the Fund purchases an equity for less than its fundamental fair (or intrinsic) value as assessed by GMO, the Fund runs the risk that the market price of the equity will not appreciate or will decline (for example, if GMO’s assessment proves to be incorrect or the market fails to recognize the equity’s intrinsic value). The Fund also may purchase equities that typically trade at higher multiples of current earnings than other securities, and the market prices of these equities often are more sensitive to changes in future earnings expectations and interest rates than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Management and Operational Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Management and Operational Risk − The Fund runs the risk that GMO’s investment techniques will fail to produce intended results. GMO uses quantitative models as part of its investment process. GMO’s models may not accurately predict future market movements. In addition, GMO’s models rely on assumptions and data that are subject to limitations (e.g., inaccuracies, staleness) that could adversely affect their predictive value. The Fund also runs the risk that GMO’s assessment of an investment, including a security’s fundamental fair (or intrinsic) value, is wrong or that deficiencies in GMO’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Market Disruption and Geopolitical Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Market Disruption and Geopolitical Risk − Geopolitical and other events (e.g., wars, pandemics, sanctions, terrorism, diplomatic tensions, dramatic changes in regulatory and/or foreign policy, cyberattacks, and rapid technological developments such as artificial intelligence) often disrupt securities markets and adversely affect the general economy or particular economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could exacerbate other risks or otherwise reduce the value of the Fund’s investments.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Focused Investment Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Focused Investment Risk − Investments in countries, regions, asset classes, sectors, industries, currencies, or issuers that are subject to the same or similar risk factors and investments whose market prices are closely correlated are subject to higher overall risk than investments that are more diversified or whose market prices are not as closely correlated.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Smaller Company Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Smaller Company Risk − Smaller companies may have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers or depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Illiquidity Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Illiquidity Risk − Low trading volume, lack of a market maker, large position size, or legal restrictions increase the risk that the Fund or an underlying fund is limited or prevented from selling particular securities or closing derivative positions at desirable prices at a particular time or at all.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Derivatives and Short Sales Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Derivatives and Short Sales Risk − The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, pools of assets, rates, currencies or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, leveraging risk, commodities risk and counterparty risk. The market price of an option is affected
​
by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant index or underlying securities. The Fund typically creates short investment exposure by selling securities short or by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index. Specifically, the net asset value of the Fund’s shares will be adversely affected if the securities or other assets that are the subject of the Fund’s short exposures appreciate in value. The risk of loss associated with derivatives that provide short investment exposure and short sales of securities is theoretically unlimited.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Counterparty Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Counterparty Risk − The Fund runs the risk that the counterparty to a derivatives contract or a clearing member used by the Fund to hold a cleared derivatives contract is unable or unwilling to make timely settlement payments, return the Fund’s collateral or otherwise honor its obligations.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Leveraging Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Leveraging Risk − The use of derivatives, short sales and securities lending can create leverage. Leverage increases the Fund’s losses when the value of its investments (including derivatives) declines. In addition, the Fund’s portfolio will be leveraged if it exercises its right to delay payment on a redemption and the value of the Fund’s assets declines between the time a redemption request is treated as being received by the Fund and the time the Fund liquidates assets to fund that redemption.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | Large Transactions Risk [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
Large Transactions Risk − To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by (or caused by) that shareholder or group will require the Fund to sell investments at disadvantageous prices, disrupt the Fund’s operations, lead to temporary overexposure to the Fund’s intended investment program or force the Fund’s liquidation. The Fund also may be subject to these effects when a number of shareholders collectively redeem or sell a large amount of Fund shares.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | ETF Risks [Member]  
Prospectus [Line Items] oef_ProspectusLineItems  
Risk [Text Block] oef_RiskTextBlock
ETF Risks − The Fund’s ETF Class operates as an ETF and, as a result of this structure, ETF Class shares are exposed to the following risks:
​
•
Costs of Buying or Selling Shares Risk.   Due to the costs of buying or selling the Fund’s ETF Class shares, including brokerage commissions imposed by brokers and the variance in bid-ask spreads, frequent trading of ETF Class shares may significantly reduce investment results and an investment in ETF Class shares may not be advisable for investors who anticipate regularly making small investments.
​
•
Limited Authorized Participants, Market Makers and Liquidity Providers Risk.   Because the Fund’s ETF Class operates as an ETF, typically only a limited number of institutional investors (known as “Authorized Participants”) are authorized to purchase and redeem shares ETF Class shares directly from the Fund. Retail investors cannot transact in ETF Class shares directly with the Fund. In addition, there may be a limited number of market makers and/or liquidity providers in the marketplace to transact in ETF Class shares, there may be demand for ETF Class shares, thereby increasing the market price above net asset value (“NAV”), or lack of demand, which may decrease the market price below NAV, or in stressed market conditions, the market for ETF Class shares may become less liquid in response to deteriorating liquidity in the markets for the Fund’s underlying portfolio holdings. As a result of these considerations, ETF Class shares may trade at a material premium or discount to their NAV or these factors may, in turn, lead to wider spreads between the bid and ask price of ETF Class shares. In addition, the ETF Class shares may face possible delisting if: (i) Authorized Participants exit the business or otherwise become unable to process creation and/or redemption orders and no other Authorized Participants step forward to perform these services, or (ii) market makers and/or liquidity providers exit the business or significantly reduce their business activities and no other entities step forward to perform their functions.
​
•
Trading Risk.   The Fund’s ETF Class shares may trade on the NYSE Arca, Inc. (the “Exchange”) above (premium) or below (discount) their NAV. In stressed market conditions, the market for ETF Class shares may become less liquid in response to deteriorating liquidity in the markets for the Fund’s underlying portfolio holdings, which may increase the variance between the market price of the ETF Class shares and the value of the Fund’s underlying holdings attributable to ETF Class shares. This can be reflected as a spread between the bid and ask prices for the ETF Class shares quoted during the day or a premium or discount in the closing price from their NAV. In addition, although the Fund’s ETF Class shares are currently listed on the Exchange, there can be no assurance that an active trading market for ETF Class shares will develop or be maintained. Trading in ETF Class shares may be halted due to market conditions or for reasons that, in the view of the Exchange, make trading in ETF Class shares of the Fund inadvisable.
​
•
Cash Transactions Risk.   The Fund may effect some of its creations and redemptions of ETF Class shares for cash, rather than in-kind securities. As a result, the Fund may have to sell portfolio securities at inopportune times in order to obtain the cash needed to meet redemption orders. This may cause the Fund to sell a security and recognize ordinary income, or a capital gain or loss that might not have been incurred if it had made a redemption in-kind. The use of cash creations and redemptions may also cause the Fund’s ETF Class shares to trade in the market at wider bid-ask spreads or greater premiums or discounts to their NAV. In effecting creations and redemptions in ETF Class shares in exchange for cash, the Fund may incur certain costs, including brokerage costs in connection with investing cash received and may recognize capital gains in connection with cash redemptions, unlike an ETF that effects creations and redemptions only in-kind. In addition, costs could be imposed on the Fund which would have the effect of decreasing the Fund’s NAV to the extent the costs are not offset by a transaction fee payable by an Authorized Participant.
​
•
National Closed Market Trading Risk.   To the extent that the underlying securities or other instruments held by the Fund trade on foreign exchanges or in foreign markets that may be closed when the securities exchange on which the Fund’s ETF Class shares trade is open, there are likely to be deviations between the current price of such an underlying security and the last quoted price for the underlying security (i.e., the Fund’s quote from the closed foreign market). The impact of a closed foreign market on the Fund is likely to be greater where a large portion of the Fund’s underlying securities or other instruments trade on that closed foreign market or when the foreign market is closed for unscheduled reasons. These deviations could result in premiums or discounts to the NAV of the Fund’s ETF Class shares that may be greater than those experienced by other ETFs.
GMO U.S. Equity Fund | GMO U.S. Equity Fund | ETF Class  
Prospectus [Line Items] oef_ProspectusLineItems  
Management Fees (as a percentage of Assets) oef_ManagementFeesOverAssets 0.46% [1]
Distribution and Service (12b-1) Fees oef_DistributionAndService12b1FeesOverAssets 0.00%
Other Expenses (as a percentage of Assets): oef_OtherExpensesOverAssets 0.24% [2]
Expenses (as a percentage of Assets) oef_ExpensesOverAssets 0.70%
Fee Waiver or Reimbursement oef_FeeWaiverOrReimbursementOverAssets (0.21%) [1]
Net Expenses (as a percentage of Assets) oef_NetExpensesOverAssets 0.49%
Expense Example, with Redemption, 1 Year oef_ExpenseExampleYear01 $ 50
Expense Example, with Redemption, 3 Years oef_ExpenseExampleYear03 203
Expense Example, with Redemption, 5 Years oef_ExpenseExampleYear05 359
Expense Example, with Redemption, 10 Years oef_ExpenseExampleYear10 $ 851
GMO U.S. Equity Fund | S&P Composite 1500 Index (returns reflect no deduction for fees, expenses, or taxes)  
Prospectus [Line Items] oef_ProspectusLineItems  
Average Annual Return, Percent oef_AvgAnnlRtrPct 17.02% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 13.96% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 14.46% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct [3]
GMO U.S. Equity Fund | Class III  
Prospectus [Line Items] oef_ProspectusLineItems  
Annual Return [Percent] oef_AnnlRtrPct 13.58%
Annual Return [Percent] oef_AnnlRtrPct 18.46%
Annual Return [Percent] oef_AnnlRtrPct (9.78%)
Annual Return [Percent] oef_AnnlRtrPct 28.57%
Annual Return [Percent] oef_AnnlRtrPct 13.69%
Annual Return [Percent] oef_AnnlRtrPct 32.13%
Annual Return [Percent] oef_AnnlRtrPct (12.44%)
Annual Return [Percent] oef_AnnlRtrPct 21.88%
Annual Return [Percent] oef_AnnlRtrPct 20.92%
Annual Return [Percent] oef_AnnlRtrPct 22.22%
Average Annual Return, Percent oef_AvgAnnlRtrPct 22.22% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 15.82% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 13.97% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 11.65% [3]
Performance Inception Date oef_PerfInceptionDate Sep. 18, 1985
GMO U.S. Equity Fund | Class III | After Taxes on Distributions  
Prospectus [Line Items] oef_ProspectusLineItems  
Average Annual Return, Percent oef_AvgAnnlRtrPct 18.89% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 11.86% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 10.31% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 8.78% [3]
GMO U.S. Equity Fund | Class III | After Taxes on Distributions and Sales  
Prospectus [Line Items] oef_ProspectusLineItems  
Average Annual Return, Percent oef_AvgAnnlRtrPct 15.20% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 11.51% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 10.19% [3]
Average Annual Return, Percent oef_AvgAnnlRtrPct 8.76% [3]
[1] Includes both management fee of 0.31% and class-specific service and supplemental support fee of 0.15% for ETF Class shares. Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) has contractually agreed to reimburse the Fund for the portion of its “Specified Operating Expenses” ​(as defined below) that exceeds 0.02% of the Fund’s average daily net assets. If the Fund has outstanding ETF Class shares, the reimbursement will be implemented at the share class level. “Specified Operating Expenses” means only the following expenses: audit expenses, fund accounting and administration expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses (excluding, in the case of Class I shares, any amounts paid for sub-transfer agency, recordkeeping and other administrative services provided by financial intermediaries for the benefit of Class I shareholders), expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees, custody expenses and exchange listing fees. GMO also has contractually agreed to waive or reduce the Fund’s management fees and service and supplemental support fees to the extent necessary to offset the management fees and service and supplemental support fees paid to GMO that are directly or indirectly borne by the Fund or a class of shares of the Fund as a result of the Fund’s direct or indirect investments in other series of GMO Trust and GMO-managed ETFs (“GMO Funds”). Management fees and service and supplemental support fees will not be waived below zero. These reimbursements and waivers will continue through at least September 30, 2027 and may not be terminated prior to this date without the action or consent of the Trust’s Board of Trustees.
[2] Because ETF Class shares of the Fund are new, “Other expenses” are estimated amounts for the current fiscal year based on the expenses of Class R6 shares of the Fund.
[3] The Fund is the successor to GMO U.S. Core Fund, a former series of GMO Trust that had an investment objective and investment policies and restrictions substantially identical to those of the Fund. Performance of the Fund through September 16, 2005 is that of GMO U.S. Core Fund and reflects GMO U.S. Core Fund’s annual operating expenses (0.02% higher than those of the Fund).